Imatinib Mesylate Tablets 100 mg, Rx Only, 90-count Bottle, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals Inc., Manalapan, NJ 07726, NDC 72485-202-90.
Published December 16, 2020 · Recall initiated: December 8, 2020
Summary
FDA records drug Class II recall D-0124-2021, published December 16, 2020 and initiated December 8, 2020. Recalling firm: Shilpa Medicare Limited; Status: Terminated; Reported quantity: 2611 bottles; Lot: Lot #s: 7S10033B, 7S10033A, 7S10031A, Exp. 02/28/2021. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations
What to do
Voluntary: Firm initiated · Letter
Get an email if IMATINIB MESYLATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- IMATINIB MESYLATE
- Manufacturer
- Shilpa Medicare Limited
- Distributor
- Nationwide in the U.S.
- Lot
- Lot #s: 7S10033B, 7S10033A, 7S10031A, Exp. 02/28/2021.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDAImatinib Mesylate Tablets 400 mg, Rx Only, 30-count Bottle, Manufactured by: Shilpa Medicare Limited, India,December 16, 2020
- FDAAzacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single DoseDecember 16, 2020
- FDAAzacitidine for Injection 100 mg/vial, For Subcutaneous and Intravenous Use Only, Rx Only, One Single DoseDecember 16, 2020
- FDADocetaxel Injection USP 160 mg/8mL (20 mg/mL), For Intravenous Infusion Only, Rx Only, 8 mL Single Use Vial,December 16, 2020
- FDABusulfan Injection 60 mg/10 mL (6 mg/mL), For Intravenous Infusion Only, Must be diluted before use, SingleDecember 16, 2020
- FDAScandonest 3% Plain (Mepivacaine Hydrochloride 3% without Vasoconstrictor), packaged in cartons of 50December 16, 2020
Questions about this recall
Was Imatinib Mesylate Tablets 100 mg, Rx Only, 90-count Bottle, Manufactured by: Shilpa Medicare Limited, India, Distributed by: Armas Pharmaceuticals Inc., Manalapan, NJ 07726, NDC 72485-202-90. recalled?
Yes. FDA published recall D-0124-2021 on December 16, 2020. Reported hazard: CGMP Deviations
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: IMATINIB MESYLATE.